Levin Capital Strategies’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
2025
Q3
$175K Buy
2023
Q4
Sell
2023
Q3
$70.7K Sell
2023
Q2
$168K Sell
2023
Q1
$1.09M Sell
2022
Q4
$761K Buy
2022
Q3
$1.06M Buy
2022
Q2
$533K Buy
2020
Q3
Sell
2020
Q2
$614K Buy
2020
Q1
$148K Sell
2019
Q4
$178K Buy